Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy

Introduction:Latent tuberculosis infection (LTBI) is detected with the tuberculin skin test (TST) before anti-TNF therapy. We aimed to investigate in vitro blood assays with TB-specific antigens (CFP-10, ESAT-6), in immune-mediated inflammatory diseases (IMID) for LTBI screening.Patients and methods...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2007-12, Vol.66 (12), p.1610-1615
Hauptverfasser: Sellam, Jérémie, Hamdi, Haifa, Roy, Carine, Baron, Gabriel, Lemann, Marc, Puéchal, Xavier, Breban, Maxime, Berenbaum, Francis, Humbert, Marc, Weldingh, Karin, Salmon, Dominique, Ravaud, Philippe, Emilie, Dominique, Mariette, Xavier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction:Latent tuberculosis infection (LTBI) is detected with the tuberculin skin test (TST) before anti-TNF therapy. We aimed to investigate in vitro blood assays with TB-specific antigens (CFP-10, ESAT-6), in immune-mediated inflammatory diseases (IMID) for LTBI screening.Patients and methods:Sixty-eight IMID patients with (n = 35) or without (n = 33) LTBI according to clinico-radiographic findings or TST results (10 mm cutoff value) underwent cell proliferation assessed by thymidine incorporation and PKH-26 dilution assays, and IFNγ-release enzyme-linked immunosorbent spot (ELISPOT) assays with TB-specific antigens.Results:In vitro blood assays gave higher positive results in patients with LTBI than without (p0.3) and lower results than those with LTBI (p
ISSN:0003-4967
1468-2060
DOI:10.1136/ard.2007.069799